Mu Zhenni, Shen Sinan, Lei Lei
College of Integrated Traditional Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha, China.
Front Med (Lausanne). 2022 Oct 19;9:1030004. doi: 10.3389/fmed.2022.1030004. eCollection 2022.
Resistant ovary syndrome (ROS) is a rare and difficult gynecological endocrine disorder that poses a serious risk to women's reproductive health. The clinical features are normal sex characteristics, regular female karyotype, and usual ovarian reserve, but elevated endogenous gonadotropin levels and low estrogen levels with primary or secondary amenorrhea. Although there have been many case reports of the disease over the past 50 years, the pathogenesis of the disease is still poorly understood, and there are still no effective clinical management strategies. In this review, we have collected all the current reports on ROS and summarized the pathogenesis and treatment strategies for this disease, intending to provide some clinical references for the management and treatment of this group of patients and provide the foothold for future studies.
抵抗性卵巢综合征(ROS)是一种罕见且棘手的妇科内分泌疾病,对女性生殖健康构成严重风险。其临床特征为性征正常、女性核型正常、卵巢储备通常,但内源性促性腺激素水平升高且雌激素水平降低,并伴有原发性或继发性闭经。尽管在过去50年中有许多关于该疾病的病例报告,但对其发病机制仍知之甚少,且仍没有有效的临床管理策略。在本综述中,我们收集了目前所有关于ROS的报告,并总结了该疾病的发病机制和治疗策略,旨在为这组患者的管理和治疗提供一些临床参考,并为未来的研究提供立足点。